Market Cap 2.83M
Revenue (ttm) 0.00
Net Income (ttm) -15.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 148,500
Avg Vol 483,586
Day's Range N/A - N/A
Shares Out 2.34M
Stochastic %K 46%
Beta -0.12
Analysts Strong Sell
Price Target $21.25

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology
Sector: Healthcare
Phone: (650) 800-3717
Address:
4660 La Jolla Village Drive, Suite 100, San Diego, United States
RCInvestor
RCInvestor Oct. 24 at 3:56 PM
$REVB $ONCO started a position .. fda meeting end of october expect some news
0 · Reply
_Sensei_
_Sensei_ Oct. 24 at 3:30 PM
0 · Reply
Greyghost013
Greyghost013 Oct. 24 at 2:03 PM
0 · Reply
Chronlogic
Chronlogic Oct. 24 at 4:17 AM
$REVB what a turd burgler
0 · Reply
smallcapexpert
smallcapexpert Oct. 23 at 3:36 PM
$REVB worth a entry here?
1 · Reply
revueltoL
revueltoL Oct. 23 at 12:25 AM
$REVB beyond meat now 😀
0 · Reply
Greyghost013
Greyghost013 Oct. 22 at 5:16 PM
$REVB slow bleed seems never ending
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR is built for asymmetry. Low float, clean structure, tangible backing, and technically it’s lining up for a major move. This isn’t about chasing hype it’s about spotting value + structure + technicals before everyone else wakes up. $BJDX $WLDS $CRKN $REVB
0 · Reply
revueltoL
revueltoL Oct. 21 at 4:15 PM
$REVB will it drop below $1? likely... a 100-200% bounce afterward? also likely…classic penny stock behavior…active warrants, dilution and delisting risks, no clear catalyst, fading retail appetite and year end tax loss selling…
2 · Reply
dantervg
dantervg Oct. 21 at 2:36 PM
$REVB I have no option to wait and be patient. Big bag holder here.🤣🤣🤣
0 · Reply
Latest News on REVB
Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Jan 6, 2025, 6:00 AM EST - 10 months ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing


RCInvestor
RCInvestor Oct. 24 at 3:56 PM
$REVB $ONCO started a position .. fda meeting end of october expect some news
0 · Reply
_Sensei_
_Sensei_ Oct. 24 at 3:30 PM
0 · Reply
Greyghost013
Greyghost013 Oct. 24 at 2:03 PM
0 · Reply
Chronlogic
Chronlogic Oct. 24 at 4:17 AM
$REVB what a turd burgler
0 · Reply
smallcapexpert
smallcapexpert Oct. 23 at 3:36 PM
$REVB worth a entry here?
1 · Reply
revueltoL
revueltoL Oct. 23 at 12:25 AM
$REVB beyond meat now 😀
0 · Reply
Greyghost013
Greyghost013 Oct. 22 at 5:16 PM
$REVB slow bleed seems never ending
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR is built for asymmetry. Low float, clean structure, tangible backing, and technically it’s lining up for a major move. This isn’t about chasing hype it’s about spotting value + structure + technicals before everyone else wakes up. $BJDX $WLDS $CRKN $REVB
0 · Reply
revueltoL
revueltoL Oct. 21 at 4:15 PM
$REVB will it drop below $1? likely... a 100-200% bounce afterward? also likely…classic penny stock behavior…active warrants, dilution and delisting risks, no clear catalyst, fading retail appetite and year end tax loss selling…
2 · Reply
dantervg
dantervg Oct. 21 at 2:36 PM
$REVB I have no option to wait and be patient. Big bag holder here.🤣🤣🤣
0 · Reply
Gladiator24
Gladiator24 Oct. 21 at 2:33 PM
$REVB wtf !
0 · Reply
Chickendinner1
Chickendinner1 Oct. 21 at 2:19 PM
$REVB no bottom. Headed to .50s
0 · Reply
SETRADING126
SETRADING126 Oct. 20 at 7:57 PM
$REVB ADDING (Again)!! 😀👏🥳🎉 123K VOL
0 · Reply
StockHounding
StockHounding Oct. 19 at 4:18 PM
$BCG is still massively misunderstood down here. You can see clear algorithmic accumulation between $2.30–$2.50 and they keep shaking weak hands before walking it back up. But filings don’t lie—the 5/15 8-K showed no dilution event, no ATM trigger, no convertible death spiral. That’s why the chart keeps building higher lows—clean cap table + real revenue = real swing potential. Once this reclaims $2.75 with volume, it wakes scanners again. $REVB low float rotation vibes $EDSA range tightening $BNZI golden cross watch $UOKA liquidity reload Don’t overthink the noise—the market ALWAYS finds the clean ticker. $BCG is loading before expansion. You’re either early or emotional. 🚀
0 · Reply
Miok
Miok Oct. 18 at 5:24 AM
$REVB pump on offering..
0 · Reply
Miok
Miok Oct. 18 at 5:20 AM
$REVB did they release the data yet? Top-line data including safety, tolerability, and biomarkers of target activity are expected by mid-year. Data from the PRIME clinical study will support future development in both the GEM-CKD and GEM-AKI programs.
0 · Reply
Chickendinner1
Chickendinner1 Oct. 17 at 7:40 PM
$REVB anyone bag holding with me?
1 · Reply
SidneyRittinger147
SidneyRittinger147 Oct. 17 at 3:36 PM
$REVB driving biotech growth while AITX drives multi-sector AI deployments — healthcare, logistics, and construction clients are fueling this surge.
0 · Reply
More_is_NeverEnough
More_is_NeverEnough Oct. 16 at 5:16 PM
$REVB just slapped 7500 shares
0 · Reply
Chickendinner1
Chickendinner1 Oct. 16 at 3:37 PM
$REVB is this good or bad?
1 · Reply
_Sensei_
_Sensei_ Oct. 16 at 3:22 PM
$REVB on scanners again 🤔
1 · Reply
RealRainmaker
RealRainmaker Oct. 15 at 9:35 PM
$REVB meeting adjourned could pump
1 · Reply